The vitamin D resistant disorders include a varied group of none diseases refractory to treatment. At present, limited knowledge regarding the pathophysiology of many such disorders precludes effective therapy. X-linked hypophosphatemic rickets (XLH) is the prototypic hypophosphatemic vitamin D resistant disease, characterized by renal phosphate (Pi) wasting, aberrant regulation of vitamin D metabolism and defective bone mineralization. Although these abnormalities are representative of those exhibited by many of the hypophosphatemic vitamin D resistant diseases, defective regulation of vitamin D metabolism is a variable derangement. Indeed, similar variability is exhibited by the murine homologues of the human diseases, the hyp- and gy-mouse. Our proposed studies are designed to continue investigation of the pathophysiological and genetic abnormalities underlying XLH and to further improve the treatment for affected subjects. Studies in the murine homologues will be employed to gain further insight to the pathophysiological mechanism(s) operative in this disease. Employing renal cross-transplantation we will explore of the abnormal renal Pi transport in the various mutant mice is uniformly due to an hormonal/Metabolic aberration (as documented in hyp-mice) or variably due to an intrinsic derangement of renal tubular function. In addition, we will use a variety of approaches to investigate the relationship between abnormal renal Pi transport and aberrant regulation of 1,25(OH)2D production. In renal cross-transplantation studies of hyp- mice, we will assess renal Pi transport and assay 25(OH)D-1- hydroxylase in the resultant animal models to determine the linkage between these abnormalities. In contrast, employing cultures of cells from the S1, S2, and S3 segments of the proximal concolutes tubules from hyp- and gy- mice, we will determine if occurrence of the Pi transport defect at alternate loci or unique distribution of 25(OH)D-1-hydroxylase activity underlies the variable occurrence of normal vitamin D metabolism in the hypophosphatemic vitamin D resistant diseases. Studies in the hyp-mouse will also include efforts to identify and characterize the humoral factor apparently underlying the abnormal renal Pi transport in this animal model. In these investigations we will assess the biological characteristics of the Pi transport inhibitory activity present in serum from hyp-mice and explore the liver as the potential organ that synthesizes this humoral factor. Additionally, we will use standard techniques to isolate the protein factor from the serum and perform structural analysis. Efforts to elucidate the genetic abnormality in XLH will be directed at localizing and eventually cloning the gene responsible for this disease. These studies will include linkage analysis, physical mapping of the Xp22.1 region ad ultimately fine structure mapping techniques. Finally, evaluation of the therapeutic strategy for XLH will place emphasis on determining if adjuvant growth hormone therapy is advantageous in the subgroup of subjects who do not exhibit growth acceleration in response to contemporary treatment. Collectively the planned studies will provide important new information regarding the pathogenesis of XLH and related vitamin D resistant diseases and potentially improve the therapeutic strategy for these disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR027032-14
Application #
3155495
Study Section
General Medicine B Study Section (GMB)
Project Start
1980-08-01
Project End
1996-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
14
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Binkley, N; Lappe, J; Singh, R J et al. (2015) Can vitamin D metabolite measurements facilitate a ""treat-to-target"" paradigm to guide vitamin D supplementation? Osteoporos Int 26:1655-60
Pfund, Christine; House, Stephanie C; Asquith, Pamela et al. (2014) Training mentors of clinical and translational research scholars: a randomized controlled trial. Acad Med 89:774-82
Feng, Jian Q; Clinkenbeard, Erica L; Yuan, Baozhi et al. (2013) Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia. Bone 54:213-21
Gibson, Monica Prasad; Zhu, Qinglin; Wang, Suzhen et al. (2013) The rescue of dentin matrix protein 1 (DMP1)-deficient tooth defects by the transgenic expression of dentin sialophosphoprotein (DSPP) indicates that DSPP is a downstream effector molecule of DMP1 in dentinogenesis. J Biol Chem 288:7204-14
Sorkness, Christine A; Pfund, Christine; Asquith, Pamela et al. (2013) Research mentor training: initiatives of the University of Wisconsin Institute for Clinical and Translational Research. Clin Transl Sci 6:256-8
Dempster, David W; Compston, Juliet E; Drezner, Marc K et al. (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2-17
Yuan, Baozhi; Feng, Jian Q; Bowman, Stephen et al. (2013) Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype. J Bone Miner Res 28:56-72
Wang, Xiaofang; Wang, Suzhen; Li, Changcheng et al. (2012) Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice. PLoS Genet 8:e1002708
Rangiani, Afsaneh; Cao, Zhengguo; Sun, Yao et al. (2012) Protective roles of DMP1 in high phosphate homeostasis. PLoS One 7:e42329
Wang, Xiaofang; Wang, Suzhen; Lu, Yongbo et al. (2012) FAM20C plays an essential role in the formation of murine teeth. J Biol Chem 287:35934-42

Showing the most recent 10 out of 79 publications